LifeStance Health Group I... (LFST)
NASDAQ: LFST
· Real-Time Price · USD
5.47
-0.02 (-0.36%)
At close: Sep 04, 2025, 3:59 PM
5.47
0.00%
After-hours: Sep 04, 2025, 04:10 PM EDT
-0.36% (1D)
| Bid | 5.36 |
| Market Cap | 2.13B |
| Revenue (ttm) | 1.32B |
| Net Income (ttm) | -16.15M |
| EPS (ttm) | -0.04 |
| PE Ratio (ttm) | -136.75 |
| Forward PE | 137.25 |
| Analyst | Buy |
| Ask | 5.99 |
| Volume | 1,451,635 |
| Avg. Volume (20D) | 2,592,912 |
| Open | 5.46 |
| Previous Close | 5.49 |
| Day's Range | 5.37 - 5.50 |
| 52-Week Range | 3.74 - 8.61 |
| Beta | 1.13 |
About LFST
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol LFST
Website n/a
Analyst Forecast
According to 0 analyst ratings, the average rating for LFST stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock ForecastsNext Earnings Release
LifeStance Health Group Inc. is scheduled to release its earnings on
Nov 6, 2025,
before market opens.
Analysts project revenue of ... Unlock content with Pro Subscription
Analysts project revenue of ... Unlock content with Pro Subscription
3 weeks ago
+13.21%
LifeStance Health Group shares are trading higher ...
Unlock content with
Pro Subscription
4 months ago
-15.88%
LFST stock has given up its prior gain. LifeStance Health Group shares were trading higher after the company reported better-than-expected Q1 sales results.
4 weeks ago · seekingalpha.com
LifeStance Health Group, Inc. (LFST) Q2 2025 Earnings Call TranscriptLifeStance Health Group, Inc. (NASDAQ:LFST ) Q2 2025 Earnings Conference Call August 7, 2025 8:30 AM ET Company Participants David Patrick Bourdon - CEO & Director Monica Prokocki - Vice President of ...
